Dr. Daniel C. Danila, MD

  • New York, NY
  • Medical oncologist
NPI1952460172PAC ID9638221377
Medicare services, 2024
1,373
Medicare patients, 2024
338
Part D claims, 2024
1,376
Publications
51
Clinical trials
3
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 5 affiliations

Find Dr. Danila's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel C. Danila is a medical oncologist in New York, New York

Dr. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Danila's NPI, 1952460172, was assigned on December 6, 2006. Dr. Danila holds Massachusetts license 220779.

NPI and contact details
Medicare PAC ID
9638221377
NPI enumeration date
December 6, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
56
Medical school graduation
1996

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daniel C. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Daniel C. Danila is affiliated with 2 sites of care and 3 medical groups

Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Danila to 2 more medical groups and 1 home health agency, each named with a free account.

See all 5 affiliations for Dr. Danila

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Daniel C. Danila's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danila practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Danila practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel C. Danila is one of 458 medical oncologists in New York

Medical oncology is Dr. Danila's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Danila is licensed in Massachusetts.

Specialties and state licenses

  • Medical oncology, MassachusettsPrimaryLicense 220779 · taxonomy 207RX0202X

Medical oncologists near Dr. Danila

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel C. Danila billed Medicare for 1,373 services in 2024

CMS data shows 1,373 Medicare services from Dr. Danila across 6 procedure codes in 2024, for 338 Medicare patients. Medicare paid $120,894 for them.

Medicare services, 20241,373
Medicare patients338
Paid by Medicare$120,894
Procedure codes6

Dr. Danila's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 9722024: 1,0094%
Other services
2023: 02024: 364

Where Dr. Danila's Medicare services took place, 2024

  • In an office1,32496%
  • In a facility494%

Dr. Danila compared with the New York median for medical oncologists, 2024

  • Dr. Danila
  • New York median
Medicare services
1,373vs 3404.0 times
Medicare patients
338vs 1123.0 times
Part D claims
1,278vs 1309.8 times

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Danila's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Danila

Need commercial claims for Dr. Danila?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Danila and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daniel C. Danila treated 338 Medicare patients in 2024, average age 76

CMS counts 338 Medicare patients who saw Dr. Danila in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have cancer, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Danila's median patient age at 75, with 2% women.

Medicare patients, 2024338
Average age76
Average risk score2.18
Also on Medicaid7%

Dr. Danila's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Danila's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol75%
  3. High blood pressure73%
  4. Arthritis46%
  5. Ischemic heart disease39%
  6. Diabetes30%
  7. Chronic kidney disease24%
  8. Mood disorders21%

Share of Medicare patients with each condition. A patient can have several.

Dr. Danila's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women2%
  • Men97%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daniel C. Danila wrote 1,376 Medicare Part D claims in 2024

In 2024, Dr. Danila wrote 1,376 Medicare Part D claims for 187 patients. 54% of them were for generic drugs. CMS names the drug for 1,278 of them, across 14 drugs with 11 or more claims each, at $6,750,196 in total drug cost. In 2023, CMS named 1,080 claims across 14 drugs.

Part D claims, 20241,376
Drugs named by CMS14
Total drug cost$6.8M
Part D patients187

Dr. Danila's Part D claims by kind of drug, 2024

  • Generic737 claims54%
  • Brand-name639 claims46%

Dr. Danila's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Danila's Part D claims, 2024

  • Opioids2%26 of 1,376 claims
  • Antibiotics1%12 of 1,376 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0802024: 1,27818%

Drugs named by CMS: 14 in 2024, 14 in 2023.

See all prescribing by Dr. Danila

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daniel C. Danila scored 83 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Danila for performance year 2024, reported as part of a group. Dr. Danila accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Danila as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Danila's MIPS scores, performance year 2024

  • 83of 100Final score
  • 80.9of 100Quality
  • 40of 100Improvement Activities
  • 65of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Danila by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel C. Danila has 51 publications on record

Dmand AI links 51 papers to Dr. Danila, published from 2011 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Castration-Resistant, Biomarkers, Tumor and Prostatic Neoplasms. Dr. Danila has published most often in Clin Cancer Res. Dr. Danila's most frequent co-authors are Howard I. Scher, MD, Michael Morris, MD and Wassim Abida, MD, PhD.

Papers51
Years published2011 to 2025

Dr. Danila's papers by year, 2016 to 2025

Topics Dr. Danila writes about most

  • Prostatic Neoplasms, Castration-Resistant
  • Biomarkers, Tumor
  • Prostatic Neoplasms
  • Neoplastic Cells, Circulating
  • Bone Neoplasms
  • Neoplasm Metastasis
  • Receptors, Androgen
  • RNA, Messenger

Dr. Danila's most frequent co-authors

Recent publications by Dr. Danila

See all 51 publications and co-authors

See who Dr. Danila researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Danila works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daniel C. Danila has worked on 3 clinical trials

Dmand AI links Dr. Danila to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Rectal Diseases and Colorectal Neoplasms. Biosplice Therapeutics, Inc. sponsors the most, 2.

Clinical trials with Dr. Danila by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Danila's trials

  • Rectal Diseases
  • Colorectal Neoplasms

Investigators on the most trials with Dr. Danila

Recent clinical trials with Dr. Danila

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Daniel C. Danila received $71,328 in industry payments from 2016 to 2025

CMS Open Payments shows 111 general payments to Dr. Danila from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Pfizer Inc. paid the most, $15,437. It also lists 7 research payments totaling $6,400 from 2023 to 2025.

General payments to Dr. Danila by program year, 2016 to 2025

General payments to Dr. Danila by kind, 2016 to 2025

$71.3Kin total
  • Consulting fees$46,81866%
  • Speaker and faculty fees$12,37017%
  • Travel and lodging$6,98010%
  • Food and beverage$4,1596%
  • Honoraria$1,0001%

Companies that paid Dr. Danila the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Danila

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Daniel C. Danila's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel C. Danila

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel C. Danila's NPI number?

Dr. Daniel C. Danila's NPI number is 1952460172. It was assigned on December 6, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel C. Danila?

Dr. Daniel C. Danila is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Daniel C. Danila practice?

Dr. Danila practices at 1275 York Avenue, New York, NY 10065. Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Danila to 2 medical groups and 1 home health agency.

What is Dr. Daniel C. Danila's medical license number?

Dr. Danila holds Massachusetts license 220779.

Which hospitals is Dr. Daniel C. Danila affiliated with?

Dr. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Daniel C. Danila part of?

Dr. Danila is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Danila to 2 more medical groups.

Does Dr. Daniel C. Danila accept Medicare?

Yes. CMS data shows Dr. Danila billed Medicare for 1,373 services in 2024, and Dr. Danila accepts Medicare assignment.

Does Dr. Daniel C. Danila offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Danila as offering telehealth services.

What is Dr. Daniel C. Danila's MIPS score?

Dr. Danila's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.

How many Medicare patients does Dr. Daniel C. Danila see?

CMS counts 338 Medicare patients who saw Dr. Danila in 2024, with an average age of 76.

Show 6 more questionsShow fewer questions

What services does Dr. Daniel C. Danila bill to Medicare?

In 2024, Dr. Danila's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

What drugs does Dr. Daniel C. Danila prescribe most?

In 2024 Medicare Part D data, Dr. Danila's most prescribed drugs by claims were Xtandi, Prednisone and Abiraterone Acetate.

Has Dr. Daniel C. Danila received payments from drug or device companies?

CMS Open Payments shows $71,328 in general payments to Dr. Danila from 16 companies from 2016 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Daniel C. Danila been practicing?

Dr. Danila graduated from medical school in 1996, 30 years ago.

Does Dr. Daniel C. Danila do research?

Dmand AI links 51 publications to Dr. Danila, published from 2011 to 2025. Dr. Danila has worked on 3 clinical trials.

Who does Dr. Daniel C. Danila publish with?

Dr. Danila's most frequent co-authors are Howard I. Scher, MD (29 shared papers), Michael Morris, MD (11 shared papers) and Wassim Abida, MD, PhD (10 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)